Replies to post #13077 on Momenta Pharmaceuticals, Inc. (MNTA)

[DFRAI]

Jbog

I dont need cheerleaders. You have some issues

1. Company has proven their capabilities
2. Do we all understand that biosimilars are in flux due to regulatory, company specific priorities/reorganization...apparently you do not comprehend this part and you keep unloading on MNTA
3. MNTA got 90MM to support their 6-7 molecules with Baxter and to support their corporate expenses and now MNTA owns the rights to all except HUmira
What part of partnering and covering development expenses you dont get? Would it be better to raise funds otherwise?

Jbog...go save the biotech world and investors